Ethicon Surgifoam To Ship In Early Nov. At An Average Cost Of About $23
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Ethicon unit plans to commence shipments of its Surgifoam absorbable gelatin sponge for use as a hemostat in early November following FDA approval Sept. 30 via premarket approval application.
You may also be interested in...
New Products In Brief
Canada OKs transcatheter valve: Medtronic receives a medical device license from Health Canada for its Melody transcatheter pulmonary valve and Ensemble transcatheter delivery system on Jan. 10. The catheter-based therapy system is the first of its kind to treat patients with congenital and acquired structural heart disease, Medtronic says. The Melody valve and Ensemble system offer a nonsurgical means to restore effective valve function and prolong the life of prosthetic conduits, reducing the need for open heart surgeries. The device received a CE mark in 2006. Medtronic is in discussions with FDA on the design of a trial to support a PMA...
New Products In Brief
Canada OKs transcatheter valve: Medtronic receives a medical device license from Health Canada for its Melody transcatheter pulmonary valve and Ensemble transcatheter delivery system on Jan. 10. The catheter-based therapy system is the first of its kind to treat patients with congenital and acquired structural heart disease, Medtronic says. The Melody valve and Ensemble system offer a nonsurgical means to restore effective valve function and prolong the life of prosthetic conduits, reducing the need for open heart surgeries. The device received a CE mark in 2006. Medtronic is in discussions with FDA on the design of a trial to support a PMA...
Fusion Looking To Broaden FloSeal Franchise With Sponge Formulation
Fusion Medical Technologies' FloSeal sponge, which can be used both in and out of the operating room, could expand the overall market for Fusion's line of hemostatic sealant products, the company says.